Granted Patent
B1
US 7,288,546 · App. 10/369,311 · Granted Oct 30, 2007
Method and compound for inhibition of cell death
Assignee:
University of Central Florida
View Patent ↗
Loading inventors, assignments & file history…
Abstract
This invention relates to a chemical compound that inhibits the apoptotic activity of the protease Omi/HtrA2 and homologous proteins. This protease Omi/HtrA2 is present in all mammalian cells so that inhibition of apoptosis in this fashion results enhanced cellular health and therapeutic effects.
Claims (4)
1. A method of inhibiting a protein selected from the group consisting of Omi/HtrA2, L56, and bacterial HtrA comprising reacting the protein with a compound of the formula
2. A method, as in claim 1 , wherein said protein is protein L56.
3. An method, as in claim 1 , wherein said protein is bacterial HtrA.
4. A method, as in claim 1 , wherein said protein is Omi/HtrA2.
Assignments (3)
CONFIRMATORY LICENSE
Recorded Aug 23, 2013
From: UNIVERSITY OF CENTRAL FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031076/0079 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jul 11, 2012
From: UNIVERSITY OF CENTRAL FLORIDA
To: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.
Reel/Frame 028526/0720 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Feb 20, 2003
From: ZERVOS, ANTONIS S.
To: UNIVERSITY OF CENTRAL FLORIDA
Reel/Frame 013794/0505 →